Elsevier Launches SciVerse Applications Beta…Enabling the Research Community to Deliver a New Era in Scientific Search and Discovery

By Elsevier, PRNE
Monday, November 15, 2010

Release of Content APIs Empowers Developers to Create New Tools to Accelerate Science and Offers Platform for Sharing with the Global Scientific Community

AMSTERDAM, November 16, 2010 - Elsevier (www.elsevier.com) , a world-leading publisher of
scientific, technical and medical information products and services, today
announced the launch of SciVerse Applications beta, a new module within the
SciVerse platform that will empower the scientific community to develop and
share customized solutions that advance the search and discovery process
through its marketplace and developer network. Created by academic and
commercial development partners, more than a dozen applications for improving
researcher workflow and enhancing the value of existing content are now
available to be integrated directly into the core SciVerse user experience.

"Recognizing the value to bring user-generated apps to the scientific
landscape and responding to researcher need, the SciVerse Applications beta
is another major step in our commitment to help usher in a new era in
scientific search and discovery," explained Jay Katzen, Managing Director,
Academic & Government Products, Elsevier. "The current applications only
begin to illustrate the possibilities. We have many more in the pipeline from
the community and expect 2011 to be an exciting year. As the wider scientific
community becomes involved, the potential to drive innovation and accelerate
science will become exponentially greater."

The launch includes the release of content APIs from SciVerse
ScienceDirect, SciVerse Scopus and SciVerse Hub beta, as well as framework
APIs allowing applications to be integrated directly into SciVerse.
Applications can access data from hundreds of millions of articles, abstracts
and other scientific information within SciVerse, and integrate into key
parts of the SciVerse user interface such as search results pages and article
and record views across all SciVerse products. The APIs as well as access to
the tools and documentation necessary for developing applications are
available via a developer section within the module.

"I am particularly impressed that the SciVerse platform supports ontology
driven apps such as Ontology Driven Semantic Search (ODiSSea), enabling users
to efficiently locate biomedical data resources," said Nigam H. Shah, MBBS,
PhD, Assistant Professor of Medicine, Stanford University and an investigator
with the National Center for Biomedical Ontology (NCBO) led by Dr. Mark Musen
(bmir.stanford.edu/people/view.php/mark_a_musen/). "ODiSSea
automatically detects biomedical concepts such as diseases, body parts, drug
names, etc entered by a user on SciVerse Hub beta and retrieves corresponding
clinical trials, drugbank records and experimental datasets from the NCBO
Resource Index." The NCBO Resource Index (
www.bioontology.org/resources-index), one of the largest repositories
of computationally generated annotations on records from public data sources
in biomedicine, was the winning entry in the Semantic Web Challenge
(challenge.semanticweb.org/) at the recently concluded International
Semantic Web Conference 2010 in Shanghai.

SciVerse Applications beta features a gallery where apps developed can be
displayed and shared. Users will be able to post feedback on individual
applications offering valuable insight for enhancing apps as well as sparking
ideas for new solutions. Developers will have an opportunity to reach the
global scientific community, while also gaining recognition for their
contribution to search and discovery.

The marketplace includes more than a dozen new search and discovery
applications designed to offer a preliminary illustration of the capabilities
of the new platform. Some of the applications available include:

    - eReader Formats: Converts articles for viewing on any eBook device
    - Table Download: Allows users to download data tables from an article
      into Excel, saving time and increasing efficiency
    - My Workflow Search: Enables users to find experimental workflows and
      connect with people doing similar experiments
    - ODiSSea: Semantically broaden a search utilizing medical and biology
      ontologies and retrieve relevant results from four commonly used data
      resources (e.g.,ClinicalTrials.gov, DrugBank, OMIM, Research
    - Quantifind: Allows users to discover a new way of searching, leveraging
      data rather than traditional keyword search to uncover emerging trends
      and correlations

As academic and commercial developers build and share new apps, SciVerse
Applications beta will be populated with innovative and tailored solutions.
To support the collaboration and ideation of the new applications, the new
offering also includes a discussion forum for researchers and librarians who
are registered SciVerse users to contribute application ideas as well as an
opportunity for developers to connect with each other and commercial

"Given the quality and scope of Elsevier content as well as its reach
within the scientific community, we were excited to collaborate in creating a
data analytics application for the SciVerse platform," said Ari Tuchman, CEO
and co-founder of Quantifind Inc. "We developed an application that
contextualizes and aggregates data from SciVerse to allow researchers to
efficiently discover emerging trends and correlations and gain unexpected new

For more information about SciVerse, please visit

About the Elsevier SciVerse Suite

The SciVerse (www.sciverse.com) suite of search and discovery
offerings provides the global research community access to a constantly
expanding universe of content and solutions which can now be accessed in one
platform. The suite currently includes SciVerse ScienceDirect (
www.sciencedirect.com), the world's largest source of peer-reviewed
content containing more than 10 million articles, and SciVerse Scopus
(www.scopus.com), an abstract and citation database containing 41
million records, 70% with abstracts and nearly 18,000 titles from 5,000
publishers worldwide. The new platform also includes SciVerse Hub beta
(www.hub.sciverse.com), which enables researchers to perform a single
search across all of the SciVerse content as well as targeted web content
with results ranked by relevancy and without duplication. SciVerse
Applications beta (www.applications.sciverse.com), a new module within
the suite, is a marketplace and developer network that allows the scientific
community to build, find and use applications that enhance the SciVerse
research experience.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.nl/), Reaxys (https://www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media contact
    Jen Saunders/Sandra Plasse
    Phone: +1-212-752-8338
    Email: splasse@psbpr.com

Media contact: Jen Saunders/Sandra Plasse, Phone: +1-212-752-8338, Email: splasse at psbpr.com, jsaunders at psbpr.com

will not be displayed